tiprankstipranks
Advertisement
Advertisement

InMode Reshapes Leadership with New Chairman and CFO in May 2026

Story Highlights
  • InMode appointed corporate governance specialist Dr. Shlomo Nass as chairman and independent director on May 19, 2026, replacing retiring chairman Michael Anghel and tightening its focus on audit, financial oversight and regulatory compliance.
  • On May 20, 2026, InMode named long-time internal finance executive Moshe Itzkovich as chief financial officer, succeeding outgoing CFO Yair Malca and emphasizing leadership continuity to support the company’s long-term strategic and financial goals.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
InMode Reshapes Leadership with New Chairman and CFO in May 2026

Meet Samuel – Your Personal Investing Prophet

InMode ( (INMD) ) has issued an announcement.

InMode announced governance and leadership changes in May 2026, appointing corporate law and finance expert Dr. Shlomo Nass as chairman of the board and independent Class II director, effective May 19, 2026, following the May 5, 2026 retirement of former chairman Michael Anghel. Nass will also chair the audit and investment committee and serve on the compensation, nominating and corporate governance committee, signaling a strengthened focus on financial oversight and regulatory compliance.

On May 20, 2026, the company named long-time finance executive Moshe (Moshik) Itzkovich as chief financial officer, effective May 19, 2026, replacing outgoing CFO Yair Malca, who will remain as a consultant to ensure a smooth transition. The elevation of an internal finance leader with regional experience in North America and Europe is intended to provide continuity and support InMode’s long-term strategic and financial objectives while maintaining a strong balance sheet and operational foundations.

The most recent analyst rating on (INMD) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on InMode stock, see the INMD Stock Forecast page.

Spark’s Take on INMD Stock

According to Spark, TipRanks’ AI Analyst, INMD is a Outperform.

The score is driven primarily by strong financial quality—high margins, strong cash generation, and an exceptionally conservative balance sheet—partly offset by the multi-year slowdown and margin compression. Technical indicators are neutral-to-weak with limited momentum, while valuation is moderate (P/E ~18.75). The latest earnings call supports a stabilization narrative via reiterated guidance and buybacks, but near-term profitability pressure and macro demand headwinds remain key risks.

To see Spark’s full report on INMD stock, click here.

More about InMode

InMode Ltd. is a leading global provider of innovative medical technologies that develops, manufactures and markets devices based on minimally invasive radiofrequency technology. The company focuses on enabling new surgical procedures and enhancing existing treatments across specialties including plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology, with a strong presence in North America and Europe.

Average Trading Volume: 906,832

Technical Sentiment Signal: Strong Sell

Current Market Cap: $893.4M

See more data about INMD stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1